234 related articles for article (PubMed ID: 19088462)
1. Health-related quality of life in patients with neurofibromatosis type 1. A survey of 129 Italian patients.
Kodra Y; Giustini S; Divona L; Porciello R; Calvieri S; Wolkenstein P; Taruscio D
Dermatology; 2009; 218(3):215-20. PubMed ID: 19088462
[TBL] [Abstract][Full Text] [Related]
2. Impact of neurofibromatosis 1 upon quality of life in childhood: a cross-sectional study of 79 cases.
Wolkenstein P; Rodriguez D; Ferkal S; Gravier H; Buret V; Algans N; Simeoni MC; Bastuji-Garin S
Br J Dermatol; 2009 Apr; 160(4):844-8. PubMed ID: 19067713
[TBL] [Abstract][Full Text] [Related]
3. Health-related quality of life in children with neurofibromatosis type 1: contribution of demographic factors, disease-related factors, and behavior.
Krab LC; Oostenbrink R; de Goede-Bolder A; Aarsen FK; Elgersma Y; Moll HA
J Pediatr; 2009 Mar; 154(3):420-5, 425.e1. PubMed ID: 18950800
[TBL] [Abstract][Full Text] [Related]
4. Quality of life and psychological adjustment in children and adolescents with neurofibromatosis type 1.
Graf A; Landolt MA; Mori AC; Boltshauser E
J Pediatr; 2006 Sep; 149(3):348-53. PubMed ID: 16939745
[TBL] [Abstract][Full Text] [Related]
5. Parental reports of health-related quality of life in young children with neurofibromatosis type 1: influence of condition specific determinants.
Oostenbrink R; Spong K; de Goede-Bolder A; Landgraf JM; Raat H; Moll HA
J Pediatr; 2007 Aug; 151(2):182-6, 186.e1-2. PubMed ID: 17643775
[TBL] [Abstract][Full Text] [Related]
6. The self-concept of children and adolescents with neurofibromatosis type 1.
Barton B; North K
Child Care Health Dev; 2007 Jul; 33(4):401-8. PubMed ID: 17584395
[TBL] [Abstract][Full Text] [Related]
7. The burden of vitiligo: patient characteristics associated with quality of life.
Linthorst Homan MW; Spuls PI; de Korte J; Bos JD; Sprangers MA; van der Veen JP
J Am Acad Dermatol; 2009 Sep; 61(3):411-20. PubMed ID: 19577331
[TBL] [Abstract][Full Text] [Related]
8. Effects of malocclusion and its treatment on the quality of life of adolescents.
Taylor KR; Kiyak A; Huang GJ; Greenlee GM; Jolley CJ; King GJ
Am J Orthod Dentofacial Orthop; 2009 Sep; 136(3):382-92. PubMed ID: 19732673
[TBL] [Abstract][Full Text] [Related]
9. Vision- and health-related quality of life in patients with visual field loss after postchiasmatic lesions.
Gall C; Lucklum J; Sabel BA; Franke GH
Invest Ophthalmol Vis Sci; 2009 Jun; 50(6):2765-76. PubMed ID: 19117930
[TBL] [Abstract][Full Text] [Related]
10. Predictive value of café au lait macules at initial consultation in the diagnosis of neurofibromatosis type 1.
Nunley KS; Gao F; Albers AC; Bayliss SJ; Gutmann DH
Arch Dermatol; 2009 Aug; 145(8):883-7. PubMed ID: 19687418
[TBL] [Abstract][Full Text] [Related]
11. Clinicopathological study of neurofibromatosis type 1: an experience in Nigeria.
Odebode TO; Afolayan EA; Adigun IA; Daramola OO
Int J Dermatol; 2005 Feb; 44(2):116-20. PubMed ID: 15689208
[TBL] [Abstract][Full Text] [Related]
12. Café-au-lait spots in neurofibromatosis type 1 and in healthy control individuals: hyperpigmentation of a different kind?
De Schepper S; Boucneau J; Vander Haeghen Y; Messiaen L; Naeyaert JM; Lambert J
Arch Dermatol Res; 2006 Apr; 297(10):439-49. PubMed ID: 16479403
[TBL] [Abstract][Full Text] [Related]
13. Increased dental caries in people with neurofibromatosis 1.
Tucker T; Birch P; Savoy DM; Friedman JM
Clin Genet; 2007 Dec; 72(6):524-7. PubMed ID: 18001351
[TBL] [Abstract][Full Text] [Related]
14. Impact of neurofibromatosis 1 on Quality of Life: a cross-sectional study of 176 American cases.
Page PZ; Page GP; Ecosse E; Korf BR; Leplege A; Wolkenstein P
Am J Med Genet A; 2006 Sep; 140(18):1893-8. PubMed ID: 16906549
[TBL] [Abstract][Full Text] [Related]
15. Neurological complications involving the central nervous system in neurofibromatosis type 1.
Hsieh HY; Wu T; Wang CJ; Chin SC; Chen YR
Acta Neurol Taiwan; 2007 Jun; 16(2):68-73. PubMed ID: 17685129
[TBL] [Abstract][Full Text] [Related]
16. Manifestations of the tongue in Neurofibromatosis type 1.
Bongiorno MR; Pistone G; Aricò M
Oral Dis; 2006 Mar; 12(2):125-9. PubMed ID: 16476032
[TBL] [Abstract][Full Text] [Related]
17. Analysis of intrafamilial phenotypic variation in neurofibromatosis 1 (NF1).
Szudek J; Joe H; Friedman JM
Genet Epidemiol; 2002 Aug; 23(2):150-64. PubMed ID: 12214308
[TBL] [Abstract][Full Text] [Related]
18. Willingness-to-pay and quality of life in patients with vitiligo.
Radtke MA; Schäfer I; Gajur A; Langenbruch A; Augustin M
Br J Dermatol; 2009 Jul; 161(1):134-9. PubMed ID: 19298268
[TBL] [Abstract][Full Text] [Related]
19. Quality of life and pain in patients with facioscapulohumeral muscular dystrophy.
Padua L; Aprile I; Frusciante R; Iannaccone E; Rossi M; Renna R; Messina S; Frasca G; Ricci E
Muscle Nerve; 2009 Aug; 40(2):200-5. PubMed ID: 19609906
[TBL] [Abstract][Full Text] [Related]
20. The impact of pruritus on the quality of life of patients undergoing dialysis: a single centre cohort study.
Tessari G; Dalle Vedove C; Loschiavo C; Tessitore N; Rugiu C; Lupo A; Girolomoni G
J Nephrol; 2009; 22(2):241-8. PubMed ID: 19384842
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
